Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT05455229
Other study ID # PASOCA_2021
Secondary ID
Status Active, not recruiting
Phase
First received
Last updated
Start date July 22, 2021
Est. completion date December 31, 2024

Study information

Verified date October 2023
Source KU Leuven
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Increased longevity is one of the greatest success stories in public health. However, ageing is accompanied by cognitive decline which affects people's daily functioning and, if it develops to dementia, their ability to live independently. By 2050, the number of people who develop dementia will triple to 152 million. The aim of this project is to precisely examine how physical activity (PA) and sleep, both modifiable lifestyle factors, are related to cognitive function and which role they can play in optimal cognitive ageing. To do so, a longitudinal study will be conducted, with objective measures of PA, sleep and cognition in midlife and older adults. This project will meet the current need for longitudinal studies with objective PA and sleep data, as well as provide, for the first time, in-depth information on associations of type of PA (aerobic vs muscle strengthening), characteristics of sleep (quality vs quantity) with specific cognitive domains (executive function and memory). Furthermore, although PA and sleep are related, the behavioural dynamics of combinations of PA and sleep on cognition has never been studied before. To fill this gap, these relationships will be examined with an innovative statistical approach, looking at data across a 24-hour period. The resulting deeper understanding of the precise relationship between PA, sleep and cognitive function will contribute to the development of preventive interventions for maintaining cognitive health at older age.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 260
Est. completion date December 31, 2024
Est. primary completion date March 31, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 55 Years and older
Eligibility Inclusion Criteria: - Community dwelling, healthy adults aged 55 and above Exclusion Criteria: 1. has a neurodegenerative disease such as Parkinson's, Alzheimer's, MS…; or 2. has a psychiatric illness such as bipolar disorder, OCD…; or 3. has had a serious brain injury in the past year or before that is still affecting them; or 4. has had a brain haemorrhage; or 5. is currently experiencing a depressive episode; or 6. has a history of addiction or excessive alcohol abuse; or 7. uses a sleeping device (for sleep apnoea); or 8. has chronic insomnia (diagnosed insomnia); or 9. is severely limited in performing daily activities (up and down stairs, walk ...) 10. has a first-degree dementia within the family 11. scores a 23 or lower on the Montreal Cognitive Assessment

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Belgium KU Leuven Leuven Vlaams-Brabant

Sponsors (3)

Lead Sponsor Collaborator
KU Leuven Research Foundation Flanders, University Ghent

Country where clinical trial is conducted

Belgium, 

Outcome

Type Measure Description Time frame Safety issue
Primary Cognitive function (baseline) - objective: executive function and memory will be tested with Cambridge Neuropsychological Test Automated Battery (CANTAB) Executive functions and memory will be the main outcome measure for cognitive function. Executive control (planning, shifting, inhibiting, attention) and memory (visuospatial, episodic, verbal) functions will be measured objectively using an iPad with the validated CANTAB software (cambridgecognition.com). Specific tasks in the test battery:
Practice: MOT (Motor Screening Task)
Memory: PAL (Paired Associates Learning), DMS (Delayed Matching to Sample), VRM (Verbal Recognition Memory)
Executive control: MTT Multitasking Test, OTS (One Touch Stockings of Cambridge), SWM (Spatial Working Memory)
baseline
Primary Change in cognitive function (follow up 1) - objective: executive function and memory will be tested with Cambridge Neuropsychological Test Automated Battery (CANTAB) Executive functions and memory will be the main outcome measure for cognitive function. Executive control (planning, shifting, inhibiting, attention) and memory (visuospatial, episodic, verbal) functions will be measured objectively using an iPad with the validated CANTAB software (cambridgecognition.com). Specific tasks in the test battery:
Practice: MOT (Motor Screening Task)
Memory: PAL (Paired Associates Learning), DMS (Delayed Matching to Sample), VRM (Verbal Recognition Memory)
Executive control: MTT Multitasking Test, OTS (One Touch Stockings of Cambridge), SWM (Spatial Working Memory)
1 year after baseline
Primary Change in cognitive function (follow up 2) - objective: executive function and memory will be tested with Cambridge Neuropsychological Test Automated Battery (CANTAB) Executive functions and memory will be the main outcome measure for cognitive function. Executive control (planning, shifting, inhibiting, attention) and memory (visuospatial, episodic, verbal) functions will be measured objectively using an iPad with the validated CANTAB software (cambridgecognition.com). Specific tasks in the test battery:
Practice: MOT (Motor Screening Task)
Memory: PAL (Paired Associates Learning), DMS (Delayed Matching to Sample), VRM (Verbal Recognition Memory)
Executive control: MTT Multitasking Test, OTS (One Touch Stockings of Cambridge), SWM (Spatial Working Memory)
1 year after follow up 1; 2 years after baseline
Primary Cognitive function (baseline) - subjective: Cognitive Failure Questionnaire 25-items will be used to measure subjective cognitive decline by assessing self-reported frequency of failures in several cognitive domains. baseline
Primary Change in cognitive function (follow up 1) - subjective: Cognitive Failure Questionnaire 25-items will be used to measure subjective cognitive decline by assessing self-reported frequency of failures in several cognitive domains. 1 year after baseline
Primary Change in cognitive function (follow up 2) - subjective: Cognitive Failure Questionnaire 25-items will be used to measure subjective cognitive decline by assessing self-reported frequency of failures in several cognitive domains. 1 year after follow up 1; 2 years after baseline
Primary Sleep (baseline) - objective: accelerometery - characteristic 1: total sleep time Specifically ActiGraph's wGT3X-BT Activity Monitor (ActiGraph, Pensacola, FL). Placement at the wrist results in the increased wear time and accuracy of sleep measurement. Total sleep time is measured in minutes. baseline
Primary Sleep (baseline) - objective: accelerometery - characteristic 2: wake after sleep onset Specifically ActiGraph's wGT3X-BT Activity Monitor (ActiGraph, Pensacola, FL). Placement at the wrist results in the increased wear time and accuracy of sleep measurement. Wake after sleep onset is measured in minutes. baseline
Primary Sleep (baseline) - objective: accelerometery - characteristic 3: sleep efficiency Specifically ActiGraph's wGT3X-BT Activity Monitor (ActiGraph, Pensacola, FL). Placement at the wrist results in the increased wear time and accuracy of sleep measurement. Sleep efficiency is displayed in percentage. baseline
Primary Sleep (baseline) - objective: accelerometery - characteristic 4: sleep latency Specifically ActiGraph's wGT3X-BT Activity Monitor (ActiGraph, Pensacola, FL). Placement at the wrist results in the increased wear time and accuracy of sleep measurement. Sleep latency is measured in minutes. baseline
Primary Change in sleep (follow up 1) - objective: accelerometery - characteristic 1: total sleep time Specifically ActiGraph's wGT3X-BT Activity Monitor (ActiGraph, Pensacola, FL). Placement at the wrist results in the increased wear time and accuracy of sleep measurement. Total sleep time is measured in minutes. 1 year after baseline
Primary Change in sleep (follow up 1) - objective: accelerometery - characteristic 2: wake after sleep onset Specifically ActiGraph's wGT3X-BT Activity Monitor (ActiGraph, Pensacola, FL). Placement at the wrist results in the increased wear time and accuracy of sleep measurement. Wake after sleep onset is measured in minutes. 1 year after baseline
Primary Change in sleep (follow up 1) - objective: accelerometery - characteristic 3: sleep efficiency Specifically ActiGraph's wGT3X-BT Activity Monitor (ActiGraph, Pensacola, FL). Placement at the wrist results in the increased wear time and accuracy of sleep measurement. Sleep efficiency is displayed in percentage. 1 year after baseline
Primary Change in sleep (follow up 1) - objective: accelerometery - characteristic 4: sleep latency Specifically ActiGraph's wGT3X-BT Activity Monitor (ActiGraph, Pensacola, FL). Placement at the wrist results in the increased wear time and accuracy of sleep measurement. Sleep latency is measured in minutes. 1 year after baseline
Primary Change in sleep (follow up 2) - objective: accelerometery - characteristic 1: total sleep time Specifically ActiGraph's wGT3X-BT Activity Monitor (ActiGraph, Pensacola, FL). Placement at the wrist results in the increased wear time and accuracy of sleep measurement. Total sleep time is measured in minutes. 1 year after follow up 1; 2 years after baseline
Primary Change in sleep (follow up 2) - objective: accelerometery - characteristic 2: wake after Specifically ActiGraph's wGT3X-BT Activity Monitor (ActiGraph, Pensacola, FL). Placement at the wrist results in the increased wear time and accuracy of sleep measurement. Wake after sleep onset is measured in minutes. 1 year after follow up 1; 2 years after baseline
Primary Change in sleep (follow up 2) - objective: accelerometery - characteristic 3: sleep efficiency Specifically ActiGraph's wGT3X-BT Activity Monitor (ActiGraph, Pensacola, FL). Placement at the wrist results in the increased wear time and accuracy of sleep measurement. Sleep efficiency is displayed in percentage. 1 year after follow up 1; 2 years after baseline
Primary Change in sleep (follow up 2) - objective: accelerometery - characteristic 4: sleep latency Specifically ActiGraph's wGT3X-BT Activity Monitor (ActiGraph, Pensacola, FL). Placement at the wrist results in the increased wear time and accuracy of sleep measurement. Sleep latency is measured in minutes. 1 year after follow up 1; 2 years after baseline
Primary Sleep (baseline) - subjective: Pittsburgh Sleep Quality Index (PSQI) The PSQI is a reliable and validated self-report questionnaire that examines the quality of sleep in the past month. It contains of 19 self-rated questions and 5 questions rated by the bed partner or roommate (if available), covering seven sleep areas: subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleeping medication, and daytime dysfunction. Baseline
Primary Change in sleep (follow up 1) - subjective: Pittsburgh Sleep Quality Index (PSQI) The PSQI is a reliable and validated self-report questionnaire that examines the quality of sleep in the past month. It contains of 19 self-rated questions and 5 questions rated by the bed partner or roommate (if available), covering seven sleep areas: subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleeping medication, and daytime dysfunction. 1 year after baseline
Primary Change in sleep (follow up 2) - subjective: Pittsburgh Sleep Quality Index (PSQI) The PSQI is a reliable and validated self-report questionnaire that examines the quality of sleep in the past month. It contains of 19 self-rated questions and 5 questions rated by the bed partner or roommate (if available), covering seven sleep areas: subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleeping medication, and daytime dysfunction. 1 year after follow up 1; 2 years after baseline
Primary Physical activity & Sedentary behaviour (baseline) - objective: accelerometery 1 ActiGraph's wGT3X-BT Activity Monitor (ActiGraph, Pensacola, FL) will be used. It measures time spent in different intensities of physical activity as well as sedentary behaviour and sleep. Participants will be asked to wear the accelerometer continuously during seven consecutive days, day and night, at their non-dominant wrist. In addition to wearing the accelerometer, participants will be asked to fill in a daily succinct diary with: (1) bed times, nap times; (2) non-wear times during the day; and (3) specification of most seated activity. These data will be used to complete and to explain gaps in the data set later on in the software programme. The following PA outcomes will be extracted from the ActiGraph data: average time spent per day in sedentary behaviour, light PA and moderate to vigorous PA. baseline
Primary Physical activity & Sedentary behaviour (baseline) - objective: accelerometery 2 A second accelerometer will be placed on the right thigh, namely the activPAL (PAL Technologies Ltd, Glasgow, UK). This device measures postures due to its static acceleration and inclination features. It can quantify postural allocation - which is not possible with the ActiGraph - and is completely waterproof. The following additional PA outcomes will be extracted: time spent sitting/lying, standing, and walking. baseline
Primary Change in Physical activity & Sedentary behaviour (follow up 1) - objective: accelerometery 1 ActiGraph's wGT3X-BT Activity Monitor (ActiGraph, Pensacola, FL) will be used. It measures time spent in different intensities of physical activity as well as sedentary behaviour and sleep. Participants will be asked to wear the accelerometer continuously during seven consecutive days, day and night, at their non-dominant wrist. In addition to wearing the accelerometer, participants will be asked to fill in a daily succinct diary with: (1) bed times, nap times; (2) non-wear times during the day; and (3) specification of most seated activity. These data will be used to complete and to explain gaps in the data set later on in the software programme. The following PA outcomes will be extracted from the ActiGraph data: average time spent per day in sedentary behaviour, light PA and moderate to vigorous PA. 1 year after baseline
Primary Change in Physical activity & Sedentary behaviour (follow up 1) - objective: accelerometery 2 A second accelerometer will be placed on the right thigh, namely the activPAL (PAL Technologies Ltd, Glasgow, UK). This device measures postures due to its static acceleration and inclination features. It can quantify postural allocation - which is not possible with the ActiGraph - and is completely waterproof. The following additional PA outcomes will be extracted: time spent sitting/lying, standing, and walking. 1 year after baseline
Primary Change in Physical activity & Sedentary behaviour (follow up 2) - objective: accelerometery 1 ActiGraph's wGT3X-BT Activity Monitor (ActiGraph, Pensacola, FL) will be used. It measures time spent in different intensities of physical activity as well as sedentary behaviour and sleep. Participants will be asked to wear the accelerometer continuously during seven consecutive days, day and night, at their non-dominant wrist. In addition to wearing the accelerometer, participants will be asked to fill in a daily succinct diary with: (1) bed times, nap times; (2) non-wear times during the day; and (3) specification of most seated activity. These data will be used to complete and to explain gaps in the data set later on in the software programme. The following PA outcomes will be extracted from the ActiGraph data: average time spent per day in sedentary behaviour, light PA and moderate to vigorous PA. 1 year after follow up 1; 2 years after baseline
Primary Change in Physical activity & Sedentary behaviour (follow up 2) - objective: accelerometery 2 A second accelerometer will be placed on the right thigh, namely the activPAL (PAL Technologies Ltd, Glasgow, UK). This device measures postures due to its static acceleration and inclination features. It can quantify postural allocation - which is not possible with the ActiGraph - and is completely waterproof. The following additional PA outcomes will be extracted: time spent sitting/lying, standing, and walking. 1 year after follow up 1; 2 years after baseline
Primary Physical activity & Sedentary behaviour (baseline) - subjective: International Physical Activity Questionnaire - Short Form (IPAQSF) The IPAQ-SF is a 7-question measure that assesses frequency and duration of vigorous PA, moderate PA, walking during the past 7 days, as well as time spent sitting. baseline
Primary Change in Physical activity & Sedentary behaviour (follow up 1) - subjective: International Physical Activity Questionnaire - Short Form (IPAQSF) The IPAQ-SF is a 7-question measure that assesses frequency and duration of vigorous PA, moderate PA, walking during the past 7 days, as well as time spent sitting. 1 year after baseline
Primary Change in Physical activity & Sedentary behaviour (follow up 2) - subjective: International Physical Activity Questionnaire - Short Form (IPAQSF) The IPAQ-SF is a 7-question measure that assesses frequency and duration of vigorous PA, moderate PA, walking during the past 7 days, as well as time spent sitting. 1 year after follow up 1; 2 years after baseline
Primary Physical activity (baseline) - subjective: muscle strengthening activity questionnaire Translated version of Muscle-strengthening exercise: Assessing participation and influences - J. Shakespear-Druery, dr. J. Bennie, dr. Katrien De Cocker & prof. S. Biddle to assess frequency, intensity and duration. baseline
Primary Change in Physical activity (follow up 1) - subjective: muscle strengthening activity questionnaire Translated version of Muscle-strengthening exercise: Assessing participation and influences - J. Shakespear-Druery, dr. J. Bennie, dr. Katrien De Cocker & prof. S. Biddle to assess frequency, intensity and duration. 1 year after baseline
Primary Change in Physical activity (follow up 2) - subjective: muscle strengthening activity questionnaire Translated version of Muscle-strengthening exercise: Assessing participation and influences - J. Shakespear-Druery, dr. J. Bennie, dr. Katrien De Cocker & prof. S. Biddle to assess frequency, intensity and duration. 1 year after follow up 1; 2 years after baseline
Secondary Wellbeing (baseline) - Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS) The 14-item scale WEMWBS has 5 response categories, summed to provide a single score baseline
Secondary Wellbeing (follow up 1) - Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS) The 14-item scale WEMWBS has 5 response categories, summed to provide a single score 1 year after baseline
Secondary Wellbeing (follow up 2) - Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS) The 14-item scale WEMWBS has 5 response categories, summed to provide a single score 1 year after follow up 1; 2 years after baseline
Secondary Global health (baseline) - PROMIS Global health 10-item questionnaire on health baseline
Secondary Global health (baseline) - PROMIS Global health 10-item questionnaire on health 1 year after baseline
Secondary Global health (follow up 2) - PROMIS Global health 10-item questionnaire on health 1 year after follow up 1; 2 years after baseline
Secondary Depression (baseline) - The Geriatric Depression Scale (GDS-15) 15-item questionnaire on depressive symptoms baseline
Secondary Depression (follow up 1) - The Geriatric Depression Scale (GDS-15) 15-item questionnaire on depressive symptoms 1 year after baseline
Secondary Depression (follow up 2) - The Geriatric Depression Scale (GDS-15) 15-item questionnaire on depressive symptoms 1 year after follow up 1; 2 years after baseline
Secondary Loneliness (baseline) - de Jong Gierveld loneliness scale (DJG loneliness) The 11-item de Jong Gierveld loneliness scale is a multi-dimensional measure of loneliness and contains five positively worded and six negatively worded items. The items fall into four subscales; feelings of severe loneliness, feelings connected with specific problem situations, missing companionship, feelings of belongingness. baseline
Secondary Loneliness (follow up 1) - de Jong Gierveld loneliness scale (DJG loneliness) The 11-item de Jong Gierveld loneliness scale is a multi-dimensional measure of loneliness and contains five positively worded and six negatively worded items. The items fall into four subscales; feelings of severe loneliness, feelings connected with specific problem situations, missing companionship, feelings of belongingness. 1 year after baseline
Secondary Loneliness (follow up 2) - de Jong Gierveld loneliness scale (DJG loneliness) The 11-item de Jong Gierveld loneliness scale is a multi-dimensional measure of loneliness and contains five positively worded and six negatively worded items. The items fall into four subscales; feelings of severe loneliness, feelings connected with specific problem situations, missing companionship, feelings of belongingness. 1 year after follow up 1; 2 years after baseline
Secondary Social network (baseline) - Lubben Social Network Scale (LSN-6) LSNS-6 provides quantitative information on their family and friendship ties, and identifies persons at increased risk for social isolation baseline
Secondary Social network (follow up 1) - Lubben Social Network Scale (LSN-6) LSNS-6 provides quantitative information on their family and friendship ties, and identifies persons at increased risk for social isolation 1 year after baseline
Secondary Social network (follow up 2) - Lubben Social Network Scale (LSN-6) LSNS-6 provides quantitative information on their family and friendship ties, and identifies persons at increased risk for social isolation 1 year after follow up 1; 2 years after baseline
Secondary Expectations Regarding Aging (baseline) - 12-Item Expectations Regarding Aging survey 12-Item Expectations Regarding Aging baseline
Secondary Expectations Regarding Aging (follow-up 1) - 12-Item Expectations Regarding Aging survey 12-Item Expectations Regarding Aging 1 year after baseline
Secondary Expectations Regarding Aging (follow-up 2) - 12-Item Expectations Regarding Aging survey 12-Item Expectations Regarding Aging 1 year after follow up 1; 2 years after baseline
See also
  Status Clinical Trial Phase
Completed NCT03988829 - Strategic Training to Optimize Neurocognitive Functions in Older Adults N/A
Completed NCT03141281 - Intervention Comparative Effectiveness for Adult Cognitive Training N/A
Completed NCT02985580 - Effects of Blueberry Juice Consumption on Cognitive Function in Healthy Older People N/A
Completed NCT05980286 - Impact of Musical Improvisation Training on Cognitive Function in Older Adults N/A
Active, not recruiting NCT02977819 - Study in Cognitively Intact Seniors Aiming to Assess the Effects of Meditation Training N/A
Completed NCT02714426 - A 14 Week Study of Mindfulness Effects on Attentional Control in Older Adults N/A
Completed NCT05462977 - Rhythmically Entrained Exercise in Community-Dwelling Older Adults N/A
Recruiting NCT05322343 - Biobank and Brain Health in Bordeaux.
Completed NCT00935493 - Guanfacine Treatment for Prefrontal Cognitive Dysfunction in Elderly Subjects N/A
Completed NCT00599508 - Nutritional Supplementation in Cognitive Aging N/A
Terminated NCT04922710 - Physical Exercise for Augmenting Cognitive Health (PEACH) Early Phase 1
Recruiting NCT06006962 - Aging Well Through Interactions and Scientific Education - Action Plan (AgeWISE-AP) N/A
Completed NCT04904991 - Three-month Chan-Chung Qigong Improves Physical Function Performance and Quality of Life N/A
Completed NCT05672771 - The Effects of Mixed Working Memory Training on Subsequent Training Gains Among Older Adults N/A
Completed NCT03629912 - Bingocize: A Novel Mobile Application for Older Adult Health N/A
Recruiting NCT04018092 - The Revitalize Study in Older Adults at Risk for Alzheimer's Disease Phase 2
Completed NCT03677726 - Improving Sleep Continuity Through Mindfulness Training for Better Cognitive Ageing. N/A